Results for post partum thyroiditis translation from English to Slovenian

the excretion into breast milk was measured in rats at 10 days post-partum.
izločanje v materino mleko so izmerili pri podganah 10 dni po kotitvi.

serum concentrations of obinutuzumab in offspring were similar to those in the mothers on day 28 post-partum.
koncentracija obinutuzumaba v serumu pri potomcih 28. dan po porodu je bila podobna kot pri materah.

offspring exposure on day 28 post-partum suggests that obinutuzumab can cross the blood-placenta barrier.
izpostavljenost mladičev 28. dan po porodu kaže, da obinutuzumab prehaja skozi krvno-placentno pregrado.

provide effective emergency obstetric and post-partum care, including treatment for complications resulting from unsafe abortion;
zagotavljanje učinkovite nege v nujnih porodniških primerih in poporodna nega, tudi v primeru zapletov zaradi nestrokovno opravljene prekinitve nosečnosti;

a single dose study was conducted in juvenile rats aged 14, 21, 24, 28, 31 or 36 days post-partum.
Študijo z enkratnim odmerkom so izvedli na podganjih mladičih, ki so bili stari 14, 21, 24, 28, 31 oziroma 36 dni.

treatment of acute post-partum (puerperal) metritis in cases where treatment with another antimicrobial has failed.
zdravljenje akutnega poporodnega (puerperalnega) matritisa v primerih, ko zdravljenje z drugimi protimikrobnimi sredstvi ni bilo učinkovito.

treatment of acute post-partum (puerperal) metritis in cattle, in cases where treatment with another antimicrobial has failed.
zdravljenje akutnega poporodnega (puerperalnega) metritisa pri govedu v primerih, ko zdravljenje z drugimi protimikrobnimi sredstvi ni bilo učinkovito.

following oral administration of c-14 labelled gefitinib to lactating rats 14 days post partum, concentrations of radioactivity in milk were 11-19 fold higher than in blood.
po peroralni uporabi s c-14 označenega gefitiniba pri doječih podganah 14 dni po skotitvi je bila koncentracija radioaktivnosti v mleku od 11- do 19-krat večja kot v krvi.

concentrations of mepolizumab were about 1.2-2.4 times higher in infants than in mothers for several months post partum and did not affect the immune system of the infants.
koncentracija mepolizumaba je bila pri mladičih več mesecev po rojstvu približno 1,2- do 2,4-krat višja kot pri materah in ni vplivala na imunski sistem mladičev.

in a juvenile rat toxicity study, where rats were treated from day 4 post partum up to adulthood, decreased absolute weights of testes and epididymides, and reduced number of sperm in epididymides were observed after weaning.
v študiji toksičnosti pri podganjih mladičih, kjer so podgane tretirali od 4. dne po skotitvi do odraslosti, so po ukinitvi dajanja opazili zmanjšano absolutno maso testisov in obmodkov ter zmanjšano število spermijev v obmodkih.

the noael was 21 times (at day 21 post partum) and 2.3 times (day 69 post partum) the human therapeutic exposure, respectively.
raven brez neželenih učinkov (noael) je bila na 21. dan po skotitvi 21-krat višja, na 69. dan po skotitvi pa 2,3-krat višja od terapevtske izpostavljenosti pri ljudeh.

another repeat-dose toxicity study was conducted in juvenile rats 14 days post-partum for 8 weeks with aliskiren dosing at 30, 100 or 300 mg/kg/day.
drugo študijo toksičnosti pri ponavljajočih se odmerkih so izvedli na 14 dni starih podganjih mladičih, ki so jim 8 tednov dajali aliskiren v odmerkih 30, 100 ali 300 mg/kg/dan.

at 500 mg/kg, no adverse reactions were seen, including upon chronic treatment (500 mg/kg/day administered from 7 to 21 days post partum).
pri odmerkih 500 mg/kg, danih tudi pri kroničnem zdravljenju (500 mg/kg/dan danih od 7 do 21 dni po skotitvi), niso opazili neželenih učinkov.

at adult age (day 69 post partum) no effects of bosentan were detected at 1.3 (males) and 2.6 (females) times the therapeutic exposure in children with pah.
pri odrasli starosti (69. dan po skotitvi) niso opazili učinkov bosentana pri 1,3-kratniku (samci) in 2,6-kratniku (samice) izpostavljenosti pri otrocih s pah.